Operaciones de insiders

EDGAR

InspireMD, Inc.

Operaciones informadas por directores, ejecutivos y titulares de más del 10 % en los Formularios 3, 4 y 5 de la SEC, leídas del XML de cada presentación. Los códigos y su redacción son los de la SEC.

El Formulario 4 debe presentarse dentro de los dos días hábiles posteriores a la operación, por lo que las más recientes pueden no estar presentadas aún.

Ventana: operaciones con fecha desde el 16 nov 2025.

Compras en el mercado abierto (código P)
17 operaciones, 417.383 acciones
Suma de acciones × precio por acción: 496.212,07
Ventas en el mercado abierto (código S)
12 operaciones, 86.913 acciones
Suma de acciones × precio por acción: 127.012,533

Los totales suman las operaciones presentadas que se listan; cuentan lo informado y no miden una dirección.

Mostrando 1–50 de 53

Operaciones de insiders, las más recientes primero, según los Formularios 3, 4 y 5 de la SEC
FechaTitular informanteCódigoAdquirido o enajenadoAccionesPrecio por acción, según lo presentadoValor (derivado)Acciones poseídas despuésDirecta o indirectaCasilla de la Regla 10b5-1NotasFuente
18 sept 2026 Presentado el 23 sept 2026ROUBIN GARY S Director
J

Other acquisition or disposition (describe transaction)

Valor derivado: Series J Warrant (right to buy) — subyacente Common Stock (15.313) — precio de ejercicio 1.3827
Enajenado (D)15.3130—15.312Directa (D) No
F1, F2
  • F1 See Exhibit 99.1; Note 1
  • F2 See Exhibit 99.1; Note 2
Abrir presentación 0001493152-26-043911 Leído del XML de la presentación Disputar esta fila
18 sept 2026 Presentado el 23 sept 2026ROUBIN GARY S Director
J

Other acquisition or disposition (describe transaction)

Valor derivado: Series J Warrant (right to buy) — subyacente Common Stock (15.313) — precio de ejercicio 0.7674
Adquirido (A)15.3130—15.313Directa (D) No
F1, F3
  • F1 See Exhibit 99.1; Note 1
  • F3 See Exhibit 99.1; Note 3
Abrir presentación 0001493152-26-043911 Leído del XML de la presentación Disputar esta fila
18 sept 2026 Presentado el 23 sept 2026ROUBIN GARY S Director
J

Other acquisition or disposition (describe transaction)

Valor derivado: Series K Warrant (right to buy) — subyacente Common Stock (30.624) — precio de ejercicio 1.3827
Enajenado (D)30.6240—0Directa (D) No
F4, F5
  • F4 See Exhibit 99.1; Note 4
  • F5 See Exhibit 99.1; Note 5
Abrir presentación 0001493152-26-043911 Leído del XML de la presentación Disputar esta fila
18 sept 2026 Presentado el 23 sept 2026ROUBIN GARY S Director
J

Other acquisition or disposition (describe transaction)

Valor derivado: Series K Warrant (right to buy) — subyacente Common Stock (30.624) — precio de ejercicio 0.7674
Adquirido (A)30.6240—30.624Directa (D) No
F4, F6
  • F4 See Exhibit 99.1; Note 4
  • F6 See Exhibit 99.1; Note 6
Abrir presentación 0001493152-26-043911 Leído del XML de la presentación Disputar esta fila
18 sept 2026 Presentado el 23 sept 2026Stuka Paul Director
J

Other acquisition or disposition (describe transaction)

Valor derivado: Series J Warrant (right to buy) — subyacente Common Stock (43.750) — precio de ejercicio 1.3827
Enajenado (D)43.7500—43.750Indirecta (I) See FootnoteNo
F1, F2, F3
  • F1 See Exhibit 99.1; Note 1
  • F2 See Exhibit 99.1; Note 2
  • F3 See Exhibit 99.1; Note 3
Abrir presentación 0001493152-26-043910 Leído del XML de la presentación Disputar esta fila
18 sept 2026 Presentado el 23 sept 2026Stuka Paul Director
J

Other acquisition or disposition (describe transaction)

Valor derivado: Series J Warrant (right to buy) — subyacente Common Stock (43.750) — precio de ejercicio 0.7674
Adquirido (A)43.7500—43.750Indirecta (I) See FootnoteNo
F1, F4, F3
  • F1 See Exhibit 99.1; Note 1
  • F4 See Exhibit 99.1; Note 4
  • F3 See Exhibit 99.1; Note 3
Abrir presentación 0001493152-26-043910 Leído del XML de la presentación Disputar esta fila
18 sept 2026 Presentado el 23 sept 2026Stuka Paul Director
J

Other acquisition or disposition (describe transaction)

Valor derivado: Series K Warrant (right to buy) — subyacente Common Stock (87.500) — precio de ejercicio 1.3827
Enajenado (D)87.5000—0Indirecta (I) See FootnoteNo
F5, F6, F3
  • F5 See Exhibit 99.1; Note 5
  • F6 See Exhibit 99.1; Note 6
  • F3 See Exhibit 99.1; Note 3
Abrir presentación 0001493152-26-043910 Leído del XML de la presentación Disputar esta fila
18 sept 2026 Presentado el 23 sept 2026Stuka Paul Director
J

Other acquisition or disposition (describe transaction)

Valor derivado: Series K Warrant (right to buy) — subyacente Common Stock (87.500) — precio de ejercicio 0.7674
Adquirido (A)87.5000—43.750Indirecta (I) See FootnoteNo
F5, F7, F3
  • F5 See Exhibit 99.1; Note 5
  • F7 See Exhibit 99.1; Note 7
  • F3 See Exhibit 99.1; Note 3
Abrir presentación 0001493152-26-043910 Leído del XML de la presentación Disputar esta fila
18 sept 2026 Presentado el 23 sept 2026BERMAN MICHAEL Director
J

Other acquisition or disposition (describe transaction)

Valor derivado: Series J Warrant (right to buy) — subyacente Common Stock (30.625) — precio de ejercicio 1.3827
Enajenado (D)30.6250—30.624Indirecta (I) See FootnoteNo
F1, F2, F3
  • F1 See Exhibit 99.1; Note 1
  • F2 See Exhibit 99.1; Note 2
  • F3 See Exhibit 99.1; Note 3
Abrir presentación 0001493152-26-043916 Leído del XML de la presentación Disputar esta fila
18 sept 2026 Presentado el 23 sept 2026BERMAN MICHAEL Director
J

Other acquisition or disposition (describe transaction)

Valor derivado: Series J Warrant (right to buy) — subyacente Common Stock (30.625) — precio de ejercicio 0.7674
Adquirido (A)30.6250—30.625Indirecta (I) See FootnoteNo
F1, F4, F3
  • F1 See Exhibit 99.1; Note 1
  • F4 See Exhibit 99.1; Note 4
  • F3 See Exhibit 99.1; Note 3
Abrir presentación 0001493152-26-043916 Leído del XML de la presentación Disputar esta fila
18 sept 2026 Presentado el 23 sept 2026BERMAN MICHAEL Director
J

Other acquisition or disposition (describe transaction)

Valor derivado: Series K Warrant (right to buy) — subyacente Common Stock (61.248) — precio de ejercicio 1.3827
Enajenado (D)61.2480—0Indirecta (I) See FootnoteNo
F5, F6, F3
  • F5 See Exhibit 99.1; Note 5
  • F6 See Exhibit 99.1; Note 6
  • F3 See Exhibit 99.1; Note 3
Abrir presentación 0001493152-26-043916 Leído del XML de la presentación Disputar esta fila
18 sept 2026 Presentado el 23 sept 2026BERMAN MICHAEL Director
J

Other acquisition or disposition (describe transaction)

Valor derivado: Series K Warrant (right to buy) — subyacente Common Stock (61.248) — precio de ejercicio 0.7674
Adquirido (A)61.2480—61.248Indirecta (I) See FootnoteNo
F5, F7, F3
  • F5 See Exhibit 99.1; Note 5
  • F7 See Exhibit 99.1; Note 7
  • F3 See Exhibit 99.1; Note 3
Abrir presentación 0001493152-26-043916 Leído del XML de la presentación Disputar esta fila
27 may 2026 Presentado el 29 may 2026Stuka Paul Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Adquirido (A)20.0000,8750
17.500

Derivado: acciones × precio por acción. Valor exacto 17500.0000.

667.871Directa (D) No
F1
  • F1 The price reported is a weighted average price. The reported securities were purchased in multiple transactions at prices ranging from $0.87 to $0.88. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
Abrir presentación 0001493152-26-026348 Leído del XML de la presentación Disputar esta fila
19 may 2026 Presentado el 21 may 2026Gleason Shane Thomas Officer: Chief Commercial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)22.7781,01
23.005,78

Derivado: acciones × precio por acción. Valor exacto 23005.78.

1.053.882Directa (D) No
F1, F2
  • F1 The sales reported on this Form 4 represent shares of common stock required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock grants pursuant to an automatic sales instruction letter adopted by the reporting person on November 25, 2024 effecting the sell-to-cover election. These sales do not represent discretionary trades by the reporting person.
  • F2 The price reported is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $1.00 to $1.04. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
Abrir presentación 0001493152-26-024864 Leído del XML de la presentación Disputar esta fila
14 may 2026 Presentado el 15 may 2026Stuka Paul Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Adquirido (A)50001,15
5750

Derivado: acciones × precio por acción. Valor exacto 5750.00.

647.871Directa (D) No— Abrir presentación 0001493152-26-023727 Leído del XML de la presentación Disputar esta fila
13 may 2026 Presentado el 15 may 2026Stuka Paul Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Adquirido (A)10.0001,1575
11.575

Derivado: acciones × precio por acción. Valor exacto 11575.0000.

642.871Directa (D) No
F1
  • F1 The price reported is a weighted average price. The reported securities were purchased in multiple transactions at prices ranging from $1.1550 to $1.1599. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
Abrir presentación 0001493152-26-023727 Leído del XML de la presentación Disputar esta fila
12 may 2026 Presentado el 13 may 2026Slosman Marvin Director · Officer: CEO and President
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Adquirido (A)21.0001,20
25.200

Derivado: acciones × precio por acción. Valor exacto 25200.00.

3.556.658Directa (D) No— Abrir presentación 0001493152-26-022775 Leído del XML de la presentación Disputar esta fila
11 may 2026 Presentado el 13 may 2026Stuka Paul Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Adquirido (A)10.0001,19
11.900

Derivado: acciones × precio por acción. Valor exacto 11900.00.

632.871Directa (D) No
F6, F4
  • F6 This Form 4/A is being filed solely to reflect that the reported transactions were not effected pursuant to a Rule 10b5-1(c) trading plan. The Form 4 filed on May 12, 2026 (the Original Filing) inadvertently checked the box that the transactions were effected pursuant to a Rule 10b5-1(c) trading plan. The Reporting Person does not currently maintain any Rule 10b5-1 trading plans. The transaction details otherwise reported in the Original Filing remain accurate and unchanged.
  • F4 The price reported is a weighted average price. The reported securities were purchased in multiple transactions at prices ranging from $1.17 to $1.20. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
Abrir presentación 0001493152-26-022763 Leído del XML de la presentación Disputar esta fila
11 may 2026 Presentado el 12 may 2026Stuka Paul Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Adquirido (A)10.0001,19
11.900

Derivado: acciones × precio por acción. Valor exacto 11900.00.

632.871Directa (D) Sí
F4
  • F4 The price reported is a weighted average price. The reported securities were purchased in multiple transactions at prices ranging from $1.17 to $1.20. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
Abrir presentación 0001493152-26-022564 Leído del XML de la presentación Disputar esta fila
8 may 2026 Presentado el 13 may 2026Stuka Paul Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Adquirido (A)65.6261,16
76.126,16

Derivado: acciones × precio por acción. Valor exacto 76126.16.

622.871Directa (D) No
F6, F1, F2, F3
  • F6 This Form 4/A is being filed solely to reflect that the reported transactions were not effected pursuant to a Rule 10b5-1(c) trading plan. The Form 4 filed on May 12, 2026 (the Original Filing) inadvertently checked the box that the transactions were effected pursuant to a Rule 10b5-1(c) trading plan. The Reporting Person does not currently maintain any Rule 10b5-1 trading plans. The transaction details otherwise reported in the Original Filing remain accurate and unchanged.
  • F1 The price reported is a weighted average price. The reported securities were purchased in multiple transactions at prices ranging from $1.15 to $1.16. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
  • F2 The Form 4 filed on August 1, 2025 (and subsequent Form 4s reflecting this information) inadvertently reported that 20,661 shares of common stock purchased on July 30, 2025 were indirectly held by the Reporting Person through Osiris Investment Partners, L.P. (Osiris). However, such shares were held directly by the Reporting Person. After adjusting for the foregoing and further technical adjustments, the Reporting Person (i) directly beneficially owned 557,245 shares of Common Stock and (ii) indirectly, through Osiris, beneficially owned 423,704 shares of Common Stock, in each case immediately prior to the transaction reported herein.
  • F3 This Form 4 reflects the Reporting Person's correct beneficial ownership following the transaction reported herein. No change in the Reporting Person's pecuniary interest resulted from these corrections.
Abrir presentación 0001493152-26-022763 Leído del XML de la presentación Disputar esta fila
8 may 2026 Presentado el 12 may 2026Stuka Paul Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Adquirido (A)65.6261,16
76.126,16

Derivado: acciones × precio por acción. Valor exacto 76126.16.

622.871Directa (D) Sí
F1, F2, F3
  • F1 The price reported is a weighted average price. The reported securities were purchased in multiple transactions at prices ranging from $1.15 to $1.16. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
  • F2 The Form 4 filed on August 1, 2025 (the Original Filing) (and subsequent Form 4s reflecting this information) inadvertently reported that 20,661 shares of common stock purchased on July 30, 2025 were indirectly held by the Reporting Person through Osiris Investment Partners, L.P. (Osiris). However, such shares were held directly by the Reporting Person. After adjusting for the foregoing and further technical adjustments, the Reporting Person (i) directly beneficially owned 557,245 shares of Common Stock and (ii) indirectly, through Osiris, beneficially owned 423,704 shares of Common Stock, in each case immediately prior to the transaction reported herein.
  • F3 This Form 4 reflects the Reporting Person's correct beneficial ownership following the transaction reported herein. No change in the Reporting Person's pecuniary interest resulted from these corrections.
Abrir presentación 0001493152-26-022564 Leído del XML de la presentación Disputar esta fila
7 may 2026 Presentado el 8 may 2026ROUBIN GARY S Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Adquirido (A)90.0001,18
106.200

Derivado: acciones × precio por acción. Valor exacto 106200.00.

834.478Directa (D) No
F1
  • F1 The price reported is a weighted average price. The reported securities were purchased in multiple transactions at prices ranging from $1.15 to $1.20. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
Abrir presentación 0001493152-26-022013 Leído del XML de la presentación Disputar esta fila
7 may 2026 Presentado el 8 may 2026Ward Scott R. Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Adquirido (A)73.2551,15
84.243,25

Derivado: acciones × precio por acción. Valor exacto 84243.25.

237.096Directa (D) No— Abrir presentación 0001493152-26-022020 Leído del XML de la presentación Disputar esta fila
7 may 2026 Presentado el 8 may 2026Stuka Paul Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Adquirido (A)63781,15
7334,7

Derivado: acciones × precio por acción. Valor exacto 7334.70.

531.599Directa (D) No
F1
  • F1 The price reported is a weighted average price. The reported securities were purchased in multiple transactions at prices ranging from $1.14 to $1.15. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
Abrir presentación 0001493152-26-022016 Leído del XML de la presentación Disputar esta fila
6 may 2026 Presentado el 8 may 2026Ward Scott R. Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Adquirido (A)15.9951,15
18.394,25

Derivado: acciones × precio por acción. Valor exacto 18394.25.

163.841Directa (D) No
F1
  • F1 The price reported is a weighted average price. The reported securities were purchased in multiple transactions at prices ranging from $1.13 to $1.15. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
Abrir presentación 0001493152-26-022020 Leído del XML de la presentación Disputar esta fila
6 may 2026 Presentado el 8 may 2026Stuka Paul Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Adquirido (A)15171,12
1699,04

Derivado: acciones × precio por acción. Valor exacto 1699.04.

525.221Directa (D) No— Abrir presentación 0001493152-26-022016 Leído del XML de la presentación Disputar esta fila
2 feb 2026 Presentado el 21 may 2026Gleason Shane Thomas Officer: Chief Commercial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)29411,59
4676,19

Derivado: acciones × precio por acción. Valor exacto 4676.19.

1.076.660Directa (D) No
F1
  • F1 The sales reported on this Form 4 represent shares of common stock required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock grants pursuant to an automatic sales instruction letter adopted by the reporting person on November 25, 2024 effecting the sell-to-cover election. These sales do not represent discretionary trades by the reporting person.
Abrir presentación 0001493152-26-024864 Leído del XML de la presentación Disputar esta fila
2 feb 2026 Presentado el 2 feb 2026Gleason Shane Thomas Officer: Chief Commercial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)20001,604
3208

Derivado: acciones × precio por acción. Valor exacto 3208.000.

1.139.177Directa (D) No
F1
  • F1 The sales reported on this Form 4 represent shares of common stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock grants pursuant to an automatic sales instruction letter adopted by the Reporting Person on November 25, 2024 effecting the sell-to-cover election. These sales do not represent discretionary trades by the Reporting Person.
Abrir presentación 0001493152-26-004773 Leído del XML de la presentación Disputar esta fila
30 ene 2026 Presentado el 2 feb 2026Gleason Shane Thomas Officer: Chief Commercial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)29001,631
4729,9

Derivado: acciones × precio por acción. Valor exacto 4729.900.

1.141.177Directa (D) No
F1
  • F1 The sales reported on this Form 4 represent shares of common stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock grants pursuant to an automatic sales instruction letter adopted by the Reporting Person on November 25, 2024 effecting the sell-to-cover election. These sales do not represent discretionary trades by the Reporting Person.
Abrir presentación 0001493152-26-004773 Leído del XML de la presentación Disputar esta fila
29 ene 2026 Presentado el 2 feb 2026Gleason Shane Thomas Officer: Chief Commercial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)50001,650
8250

Derivado: acciones × precio por acción. Valor exacto 8250.000.

1.144.077Directa (D) No
F1
  • F1 The sales reported on this Form 4 represent shares of common stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock grants pursuant to an automatic sales instruction letter adopted by the Reporting Person on November 25, 2024 effecting the sell-to-cover election. These sales do not represent discretionary trades by the Reporting Person.
Abrir presentación 0001493152-26-004773 Leído del XML de la presentación Disputar esta fila
28 ene 2026 Presentado el 2 feb 2026Gleason Shane Thomas Officer: Chief Commercial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)12.3951,651
20.464,145

Derivado: acciones × precio por acción. Valor exacto 20464.145.

1.149.077Directa (D) No
F1
  • F1 The sales reported on this Form 4 represent shares of common stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock grants pursuant to an automatic sales instruction letter adopted by the Reporting Person on November 25, 2024 effecting the sell-to-cover election. These sales do not represent discretionary trades by the Reporting Person.
Abrir presentación 0001493152-26-004773 Leído del XML de la presentación Disputar esta fila
27 ene 2026 Presentado el 2 feb 2026Gleason Shane Thomas Officer: Chief Commercial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)47811,664
7955,584

Derivado: acciones × precio por acción. Valor exacto 7955.584.

1.161.472Directa (D) No
F1
  • F1 The sales reported on this Form 4 represent shares of common stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock grants pursuant to an automatic sales instruction letter adopted by the Reporting Person on November 25, 2024 effecting the sell-to-cover election. These sales do not represent discretionary trades by the Reporting Person.
Abrir presentación 0001493152-26-004773 Leído del XML de la presentación Disputar esta fila
22 ene 2026 Presentado el 2 feb 2026Gleason Shane Thomas Officer: Chief Commercial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)84111,574
13.238,914

Derivado: acciones × precio por acción. Valor exacto 13238.914.

1.166.253Directa (D) No
F1
  • F1 The sales reported on this Form 4 represent shares of common stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock grants pursuant to an automatic sales instruction letter adopted by the Reporting Person on November 25, 2024 effecting the sell-to-cover election. These sales do not represent discretionary trades by the Reporting Person.
Abrir presentación 0001493152-26-004773 Leído del XML de la presentación Disputar esta fila
21 ene 2026 Presentado el 2 feb 2026Gleason Shane Thomas Officer: Chief Commercial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)17.5931,623
28.553,439

Derivado: acciones × precio por acción. Valor exacto 28553.439.

1.174.664Directa (D) No
F1
  • F1 The sales reported on this Form 4 represent shares of common stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock grants pursuant to an automatic sales instruction letter adopted by the Reporting Person on November 25, 2024 effecting the sell-to-cover election. These sales do not represent discretionary trades by the Reporting Person.
Abrir presentación 0001493152-26-004773 Leído del XML de la presentación Disputar esta fila
20 ene 2026 Presentado el 2 feb 2026Gleason Shane Thomas Officer: Chief Commercial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)29551,594
4710,27

Derivado: acciones × precio por acción. Valor exacto 4710.270.

1.192.257Directa (D) No
F1
  • F1 The sales reported on this Form 4 represent shares of common stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock grants pursuant to an automatic sales instruction letter adopted by the Reporting Person on November 25, 2024 effecting the sell-to-cover election. These sales do not represent discretionary trades by the Reporting Person.
Abrir presentación 0001493152-26-004773 Leído del XML de la presentación Disputar esta fila
16 ene 2026 Presentado el 2 feb 2026Gleason Shane Thomas Officer: Chief Commercial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)22501,612
3627

Derivado: acciones × precio por acción. Valor exacto 3627.000.

1.195.212Directa (D) No
F1
  • F1 The sales reported on this Form 4 represent shares of common stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock grants pursuant to an automatic sales instruction letter adopted by the Reporting Person on November 25, 2024 effecting the sell-to-cover election. These sales do not represent discretionary trades by the Reporting Person.
Abrir presentación 0001493152-26-004773 Leído del XML de la presentación Disputar esta fila
15 ene 2026 Presentado el 2 feb 2026Gleason Shane Thomas Officer: Chief Commercial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Enajenado (D)29091,579
4593,311

Derivado: acciones × precio por acción. Valor exacto 4593.311.

1.197.462Directa (D) No
F1
  • F1 The sales reported on this Form 4 represent shares of common stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock grants pursuant to an automatic sales instruction letter adopted by the Reporting Person on November 25, 2024 effecting the sell-to-cover election. These sales do not represent discretionary trades by the Reporting Person.
Abrir presentación 0001493152-26-004773 Leído del XML de la presentación Disputar esta fila
14 ene 2026 Presentado el 16 ene 2026BERMAN MICHAEL Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Adquirido (A)88.0530—352.586Directa (D) No
F1
  • F1 These shares of common stock represent shares of restricted stock that shall vest on January 14, 2027 (the One Year Grant Anniversary Date), subject to the Reporting Person's continued service.
Abrir presentación 0001493152-26-002662 Leído del XML de la presentación Disputar esta fila
14 ene 2026 Presentado el 16 ene 2026Stuka Paul Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Adquirido (A)132.0760—523.704Directa (D) No
F1
  • F1 These shares of common stock represent shares of restricted stock that shall vest on January 14, 2027 (the One Year Grant Anniversary Date), subject to the Reporting Person's continued service.
Abrir presentación 0001493152-26-002669 Leído del XML de la presentación Disputar esta fila
14 ene 2026 Presentado el 16 ene 2026Tommasoli Andrea Officer: Chief Operating Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Adquirido (A)226.6950—954.389Directa (D) No
F1
  • F1 These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of January 14, 2027, January 14, 2028 and January 14, 2028, subject to the Reporting Person's continued service.
Abrir presentación 0001493152-26-002670 Leído del XML de la presentación Disputar esta fila
14 ene 2026 Presentado el 16 ene 2026Dearen Danny L. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Adquirido (A)44.0300—102.047Directa (D) No
F1
  • F1 These shares of common stock represent shares of restricted stock that shall vest on January 14, 2027 (the One Year Grant Anniversary Date), subject to the Reporting Person's continued service.
Abrir presentación 0001493152-26-002664 Leído del XML de la presentación Disputar esta fila
14 ene 2026 Presentado el 16 ene 2026COHEN RAYMOND W Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Adquirido (A)44.0300—92.417Directa (D) No
F1
  • F1 These shares of common stock represent shares of restricted stock that shall vest on January 14, 2027 (the One Year Grant Anniversary Date), subject to the Reporting Person's continued service.
Abrir presentación 0001493152-26-002663 Leído del XML de la presentación Disputar esta fila
14 ene 2026 Presentado el 16 ene 2026Gleason Shane Thomas Officer: Chief Commercial Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Adquirido (A)453.3900—1.200.371Directa (D) No
F1
  • F1 These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of January 14, 2027, January 14, 2028 and January 14, 2029, subject to the Reporting Person's continued service.
Abrir presentación 0001493152-26-002665 Leído del XML de la presentación Disputar esta fila
14 ene 2026 Presentado el 16 ene 2026Slosman Marvin Director · Officer: CEO and President
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Restricted Stock Units
Adquirido (A)1.114.7920—3.535.658Directa (D) No
F1
  • F1 These restricted stock units vest and become exercisable in three equal annual installments, with 1/3 vesting on each of January 14, 2027, January 14, 2028 and January 14, 2029, subject to the Reporting Person's continued service.
Abrir presentación 0001493152-26-002668 Leído del XML de la presentación Disputar esta fila
14 ene 2026 Presentado el 16 ene 2026Ward Scott R. Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Adquirido (A)88.0530—147.846Directa (D) No
F1
  • F1 These shares of common stock represent shares of restricted stock that shall vest on January 14, 2027 (the One Year Grant Anniversary Date), subject to the Reporting Person's continued service.
Abrir presentación 0001493152-26-002671 Leído del XML de la presentación Disputar esta fila
14 ene 2026 Presentado el 16 ene 2026ROUBIN GARY S Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Adquirido (A)88.0530—744.478Directa (D) No
F1
  • F1 These shares of common stock represent shares of restricted stock that shall vest on January 14, 2027 (the One Year Grant Anniversary Date), subject to the Reporting Person's continued service.
Abrir presentación 0001493152-26-002667 Leído del XML de la presentación Disputar esta fila
14 ene 2026 Presentado el 16 ene 2026Lawless Michael A Officer: Chief Financial Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Adquirido (A)226.6950—691.695Directa (D) No
F1
  • F1 These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of January 14, 2027, January 14, 2028 and January 14, 2029, subject to the Reporting Person's continued service.
Abrir presentación 0001493152-26-002666 Leído del XML de la presentación Disputar esta fila
30 dic 2025 Presentado el 31 dic 2025Arnold Kathryn Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Adquirido (A)55.5560—303.087Directa (D) No
F1
  • F1 Represent grant of shares of common stock and options to purchase shares of common stock for services rendered as a director of the Issuer in 2025 prior to the Reporting Person's resignation as a director, effective December 31, 2025.
Abrir presentación 0001493152-25-029800 Leído del XML de la presentación Disputar esta fila
30 dic 2025 Presentado el 31 dic 2025Arnold Kathryn Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Valor derivado: Options to purchase common stock (right to buy) — subyacente Common Stock (26.276) — precio de ejercicio 1.89
Adquirido (A)26.2760—111.221Directa (D) No
F1
  • F1 Represent grant of shares of common stock and options to purchase shares of common stock for services rendered as a director of the Issuer in 2025 prior to the Reporting Person's resignation as a director, effective December 31, 2025.
Abrir presentación 0001493152-25-029800 Leído del XML de la presentación Disputar esta fila
9 dic 2025 Presentado el 23 feb 2026Stuka Paul Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Adquirido (A)27101,81
4905,1

Derivado: acciones × precio por acción. Valor exacto 4905.10.

391.628Directa (D) No
F1, F2
  • F1 This Form 4/A amends the Form 4 filed on December 11, 2025 solely to correct the number of shares reported in Table I, Column 4. The number of shares reported in Column 5 was correct as originally filed. No other changes have been made.
  • F2 The price reported is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $1.80 to $1.81. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
Abrir presentación 0001493152-26-007752 Leído del XML de la presentación Disputar esta fila

Titulares institucionales (Formulario 13F)

Trimestre terminado el 2026-09-30: 7211 presentaciones leídas, la última del 13 nov 2026. Trimestre anterior terminado el 2026-06-30: 9150 presentaciones leídas.

Mostrando 1–28 de 28

Titulares institucionales, la posición mayor primero, según lo presentado
GestorAcciones o principalValor según lo presentadoDiferencia con el trimestre anteriorFuente
Aberdeen Group plc Informado en parte bajo otro gestor3.698.364 SH2.482.712 dólaresSin cambios Trimestre anterior: 3.698.364Abrir presentación 0001716774-26-000032 Presentado el 10 nov 2026 Disputar esta fila
Nantahala Capital Management, LLC 3.376.484 SH2.254.816 dólaresMenor en 3.376.484 Trimestre anterior: 6.752.968Abrir presentación 0001104659-26-127125 Presentado el 13 nov 2026 Disputar esta fila
MARSHALL WACE, LLP Informado en parte bajo otro gestor1.860.405 SH1.246.471 dólaresSin cambios Trimestre anterior: 1.860.405Abrir presentación 0001318757-26-000012 Presentado el 13 nov 2026 Disputar esta fila
INGALLS SNYDER LLC 362.550 SH242 dólaresMenor en 6250 Trimestre anterior: 368.800Abrir presentación 0001041885-26-000010 Presentado el 12 nov 2026 Disputar esta fila
Affiance Financial, LLC 250.370 SH167.197 dólaresSin cambios Trimestre anterior: 250.370Abrir presentación 0001723681-26-000006 Presentado el 15 oct 2026 Disputar esta fila
UBS Group AG Informado en parte bajo otro gestor133.653 SH89.280 dólaresMayor en 128.339 Trimestre anterior: 5314Abrir presentación 0001610520-26-000121 Presentado el 10 nov 2026 Disputar esta fila
BlackRock, Inc. Informado en parte bajo otro gestor117.708 SH78.605 dólaresMenor en 5285 Trimestre anterior: 122.993Abrir presentación 0002012383-26-003985 Presentado el 13 nov 2026 Disputar esta fila
Creative Planning 108.964 SH72.766 dólaresSin cambios Trimestre anterior: 108.964Abrir presentación 0001540235-26-000006 Presentado el 2 nov 2026 Disputar esta fila
RENAISSANCE TECHNOLOGIES LLC Informado en parte bajo otro gestor87.892 SH58.694 dólaresMenor en 24.940 Trimestre anterior: 112.832Abrir presentación 0001037389-26-000062 Presentado el 12 nov 2026 Disputar esta fila
COURIER CAPITAL LLC 30.000 SH20.034 dólaresSin cambios Trimestre anterior: 30.000Abrir presentación 0001420506-26-002338 Presentado el 19 oct 2026 Disputar esta fila
Mesirow Financial Investment Management, Inc. 30.000 SH20.034 dólaresSin cambios Trimestre anterior: 30.000Abrir presentación 0001469475-26-000005 Presentado el 5 nov 2026 Disputar esta fila
Centiva Capital, LP 27.180 SH18.246 dólaresMenor en 16.943 Trimestre anterior: 44.123Abrir presentación 0001172661-26-005016 Presentado el 13 nov 2026 Disputar esta fila
VESTIA PERSONAL WEALTH ADVISORS 24.425 SH16.311 dólaresSin cambios Trimestre anterior: 24.425Abrir presentación 0002033299-26-000005 Presentado el 20 oct 2026 Disputar esta fila
JANE STREET GROUP, LLC Informado en parte bajo otro gestor20.402 SH13.625 dólaresNo figura en las presentaciones leídas del trimestre anterior Abrir presentación 0001595888-26-000162 Presentado el 12 nov 2026 Disputar esta fila
MORGAN STANLEY Informado en parte bajo otro gestor20.371 SH13.604 dólaresMenor en 8000 Trimestre anterior: 28.371Abrir presentación 0000895421-26-000309 Presentado el 13 nov 2026 Disputar esta fila
Cambridge Investment Research Advisors, Inc. 20.116 SH13 dólaresMenor en 20.216 Trimestre anterior: 40.332Abrir presentación 0001419186-26-000008 Presentado el 2 nov 2026 Disputar esta fila
HRT FINANCIAL LP 19.346 SH12 dólaresMenor en 40.408 Trimestre anterior: 59.754Abrir presentación 0001475597-26-000249 Presentado el 13 nov 2026 Disputar esta fila
LPL Financial LLC 18.621 SH12.435 dólaresSin cambios Trimestre anterior: 18.621Abrir presentación 0001403438-26-000005 Presentado el 6 nov 2026 Disputar esta fila
OSAIC HOLDINGS, INC. Informado en parte bajo otro gestor15.952 SH10.685 dólaresSin cambios Trimestre anterior: 15.952Abrir presentación 0001677044-26-000011 Presentado el 12 nov 2026 Disputar esta fila
Avestar Capital, LLC 15.000 SH10.017 dólaresSin cambios Trimestre anterior: 15.000Abrir presentación 0001172661-26-004738 Presentado el 28 oct 2026 Disputar esta fila
Pallas Capital Advisors LLC 11.000 SH7346 dólaresSin cambios Trimestre anterior: 11.000Abrir presentación 0001951757-26-001856 Presentado el 12 nov 2026 Disputar esta fila
McKinley Carter Wealth Services, Inc. 10.000 SH6678 dólaresSin cambios Trimestre anterior: 10.000Abrir presentación 0001484265-26-000004 Presentado el 16 oct 2026 Disputar esta fila
BFC Planning, Inc. 8000 SH5342 dólaresSin cambios Trimestre anterior: 8000Abrir presentación 0001420506-26-002645 Presentado el 13 nov 2026 Disputar esta fila
Farther Finance Advisors, LLC 1000 SH668 dólaresSin cambios Trimestre anterior: 1000Abrir presentación 0001992825-26-000006 Presentado el 8 oct 2026 Disputar esta fila
CITIGROUP INC Informado en parte bajo otro gestor400 SH269 dólaresMayor en 399 Trimestre anterior: 1Abrir presentación 0000831001-26-000052 Presentado el 4 nov 2026 Disputar esta fila
SIMPLEX TRADING, LLC Opción: Call 200 SH15 dólaresNo figura en las presentaciones leídas del trimestre anterior Abrir presentación 0001488542-26-000013 Presentado el 4 nov 2026 Disputar esta fila
HARBOUR INVESTMENTS, INC. 14 SH9 dólaresNo figura en las presentaciones leídas del trimestre anterior Abrir presentación 0000810121-26-000006 Presentado el 9 nov 2026 Disputar esta fila
Caitong International Asset Management Co., Ltd 1 SH1 dólaresSin cambios Trimestre anterior: 1Abrir presentación 0001628280-26-068135 Presentado el 29 oct 2026 Disputar esta fila
Gestores del trimestre anterior sin presentación leída para el último

Quizá simplemente no hayan presentado aún: estar ausente de las presentaciones leídas del último trimestre no equivale a una posición vendida.

  • Rosalind Advisors, Inc. 3.905.743 SH
  • ORBIMED ADVISORS LLC 3.133.405 SH
  • Parkman Healthcare Partners LLC 2.416.518 SH
  • Soleus Capital Management, L.P. 1.045.708 SH
  • PURA VIDA INVESTMENTS, LLC 450.517 SH
  • Velan Capital Investment Management LP 148.138 SH
  • Schonfeld Strategic Advisors LLC 99.275 SH
  • XTX Topco Ltd 49.029 SH
  • MILLENNIUM MANAGEMENT LLC 37.677 SH
  • SUSQUEHANNA INTERNATIONAL GROUP, LLP 20.594 SH
  • CITADEL ADVISORS LLC 13.600 SH
  • AdvisorNet Financial, Inc 8783 SH
  • SIMPLEX TRADING, LLC 745 SH
  • ROYAL BANK OF CANADA 247 SH
  • El Formulario 13F cubre solo posiciones largas en valores de la Sección 13(f): ni posiciones cortas ni valores fuera de esa lista.
  • Un gestor que aún no ha presentado el último trimestre está ausente, no en cero; las presentaciones vencen hasta 45 días después del cierre del trimestre.
  • Una diferencia es la que hay entre dos instantáneas de cierre de trimestre, no una operación.
  • Una posición informada bajo otro gestor puede aparecer también en la presentación de ese gestor; las filas no se suman.
  • No se muestran las posiciones que la lista de valores no puede atribuir a esta empresa o atribuye de forma ambigua.

Titulares del 5 % (Anexos 13D y 13G)

Aquí se leen los anexos presentados en el formato estructurado de la SEC (desde finales de 2024). Los anteriores son texto libre y no se leen.

Titulares del 5 %, el evento más reciente primero, según lo presentado
TitularPorcentaje de la claseAcciones en poderFecha del eventoFormularioFuente
Nantahala Capital Management, LLC Common Stock, par value $0.0001 per share9.994.819.647,0003/31/2026 Presentado el 15 may 2026SCHEDULE 13G/AEnmienda 5Abrir presentación 0001104659-26-062712 Disputar esta fila
Wilmot B. Harkey Common Stock, par value $0.0001 per share9.994.819.647,0003/31/2026 Presentado el 15 may 2026SCHEDULE 13G/AEnmienda 5Abrir presentación 0001104659-26-062712 Disputar esta fila
Daniel Mack Common Stock, par value $0.0001 per share9.994.819.647,0003/31/2026 Presentado el 15 may 2026SCHEDULE 13G/AEnmienda 5Abrir presentación 0001104659-26-062712 Disputar esta fila
Velan Capital Master Fund LP Common Stock, par value $0.0001 per share4.992.347.779,0003/31/2026 Presentado el 15 may 2026SCHEDULE 13G/AEnmienda 1Abrir presentación 0000921895-26-001363 Disputar esta fila
Velan Capital Holdings LLC Common Stock, par value $0.0001 per share4.992.347.779,0003/31/2026 Presentado el 15 may 2026SCHEDULE 13G/AEnmienda 1Abrir presentación 0000921895-26-001363 Disputar esta fila
Velan Capital Investment Management LP Common Stock, par value $0.0001 per share4.992.347.779,0003/31/2026 Presentado el 15 may 2026SCHEDULE 13G/AEnmienda 1Abrir presentación 0000921895-26-001363 Disputar esta fila
Velan Capital Management LLC Common Stock, par value $0.0001 per share4.992.347.779,0003/31/2026 Presentado el 15 may 2026SCHEDULE 13G/AEnmienda 1Abrir presentación 0000921895-26-001363 Disputar esta fila
Morgan Adam Common Stock, par value $0.0001 per share4.992.347.779,0003/31/2026 Presentado el 15 may 2026SCHEDULE 13G/AEnmienda 1Abrir presentación 0000921895-26-001363 Disputar esta fila
Venkataraman Balaji Common Stock, par value $0.0001 per share4.992.347.779,0003/31/2026 Presentado el 15 may 2026SCHEDULE 13G/AEnmienda 1Abrir presentación 0000921895-26-001363 Disputar esta fila
Marvin Slosman Common Stock, $0.0001 par value per share5.182.556.760,0001/22/2026 Presentado el 24 abr 2026SCHEDULE 13DAbrir presentación 0001493152-26-018952 Disputar esta fila
ORBIMED ADVISORS LLC Common Stock, par value $0.0001 per share7.43.133.405,0012/31/2025 Presentado el 17 feb 2026SCHEDULE 13GAbrir presentación 0000947871-26-000191 Disputar esta fila
OrbiMed Capital GP IX LLC Common Stock, par value $0.0001 per share6.82.878.704,0012/31/2025 Presentado el 17 feb 2026SCHEDULE 13GAbrir presentación 0000947871-26-000191 Disputar esta fila
Rosalind Advisors, Inc. Common Shares9.210.987.104,0012/31/2025 Presentado el 11 feb 2026SCHEDULE 13G/AEnmienda 9Abrir presentación 0001622627-26-000006 Disputar esta fila
SALAMON STEVEN A J Common Shares9.210.987.104,0012/31/2025 Presentado el 11 feb 2026SCHEDULE 13G/AEnmienda 9Abrir presentación 0001622627-26-000006 Disputar esta fila
Aharon Gil Common Shares9.210.987.104,0012/31/2025 Presentado el 11 feb 2026SCHEDULE 13G/AEnmienda 9Abrir presentación 0001622627-26-000006 Disputar esta fila
Rosalind Master Fund L.P. Common Shares8.39.485.697,0012/31/2025 Presentado el 11 feb 2026SCHEDULE 13G/AEnmienda 9Abrir presentación 0001622627-26-000006 Disputar esta fila
Rosalind Opportunities Fund I L.P. Common Shares1.01.501.407,0012/31/2025 Presentado el 11 feb 2026SCHEDULE 13G/AEnmienda 9Abrir presentación 0001622627-26-000006 Disputar esta fila
Aberdeen Group plc Common Stock, $0.0001 par value per share7.493.173.36412/31/2025 Presentado el 2 feb 2026SCHEDULE 13G/AEnmienda 1Abrir presentación 0001716774-26-000010 Disputar esta fila
abrdn Inc. Common Stock, $0.0001 par value per share7.493.173.36412/31/2025 Presentado el 2 feb 2026SCHEDULE 13G/AEnmienda 1Abrir presentación 0001716774-26-000010 Disputar esta fila
Aberdeen Group plc Common Stock, $0.0001 par value per share5.952.481.11710/01/2025 Presentado el 7 nov 2025SCHEDULE 13GAbrir presentación 0001716774-25-000006 Disputar esta fila
abrdn Inc. Common Stock, $0.0001 par value per share5.952.481.11710/01/2025 Presentado el 7 nov 2025SCHEDULE 13GAbrir presentación 0001716774-25-000006 Disputar esta fila
Nantahala Capital Management, LLC Common Stock, par value $0.0001 per share9.994.255.729,0009/30/2025 Presentado el 14 nov 2025SCHEDULE 13G/AEnmienda 1Abrir presentación 0001104659-25-112683 Disputar esta fila
Wilmot B. Harkey Common Stock, par value $0.0001 per share9.994.255.729,0009/30/2025 Presentado el 14 nov 2025SCHEDULE 13G/AEnmienda 1Abrir presentación 0001104659-25-112683 Disputar esta fila
Daniel Mack Common Stock, par value $0.0001 per share9.994.255.729,0009/30/2025 Presentado el 14 nov 2025SCHEDULE 13G/AEnmienda 1Abrir presentación 0001104659-25-112683 Disputar esta fila
Parkman Healthcare Partners LLC Common Stock, $0.0001 par value5.82.440.633,0009/30/2025 Presentado el 14 nov 2025SCHEDULE 13GAbrir presentación 0000919574-25-006898 Disputar esta fila
Parkman Healthcare Partners Holdings LP Common Stock, $0.0001 par value5.82.440.633,0009/30/2025 Presentado el 14 nov 2025SCHEDULE 13GAbrir presentación 0000919574-25-006898 Disputar esta fila
Parkman Healthcare Partners Holdings GP LLC Common Stock, $0.0001 par value5.82.440.633,0009/30/2025 Presentado el 14 nov 2025SCHEDULE 13GAbrir presentación 0000919574-25-006898 Disputar esta fila
Martinez Gregory Common Stock, $0.0001 par value5.82.440.633,0009/30/2025 Presentado el 14 nov 2025SCHEDULE 13GAbrir presentación 0000919574-25-006898 Disputar esta fila
OrbiMed Advisors LLC Common Stock, par value $0.0001 per share4.12.133.405,0009/30/2025 Presentado el 14 nov 2025SCHEDULE 13G/AEnmienda 3Abrir presentación 0000947871-25-001021 Disputar esta fila
MARSHALL WACE, LLP Common Stock, par value $0.0001 per share9.9928.103.699,0009/30/2025 Presentado el 14 nov 2025SCHEDULE 13G/AEnmienda 1Abrir presentación 0000902664-25-005052 Disputar esta fila
NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP Common Stock, par value $0.0001 per share5.67612.418.016,0009/30/2025 Presentado el 14 nov 2025SCHEDULE 13G/AEnmienda 1Abrir presentación 0001104659-25-112616 Disputar esta fila
Rosalind Advisors, Inc. Common Shares9.410.987.104,0008/01/2025 Presentado el 11 ago 2025SCHEDULE 13G/AEnmienda 8Abrir presentación 0001579206-25-000006 Disputar esta fila
SALAMON STEVEN A J Common Shares9.410.987.104,0008/01/2025 Presentado el 11 ago 2025SCHEDULE 13G/AEnmienda 8Abrir presentación 0001579206-25-000006 Disputar esta fila
Aharon Gil Common Shares9.410.987.104,0008/01/2025 Presentado el 11 ago 2025SCHEDULE 13G/AEnmienda 8Abrir presentación 0001579206-25-000006 Disputar esta fila
Rosalind Master Fund L.P. Common Shares8.49.485.697,0008/01/2025 Presentado el 11 ago 2025SCHEDULE 13G/AEnmienda 8Abrir presentación 0001579206-25-000006 Disputar esta fila
Rosalind Opportunities Fund I L.P. Common Shares0.11.501.407,0008/01/2025 Presentado el 11 ago 2025SCHEDULE 13G/AEnmienda 8Abrir presentación 0001579206-25-000006 Disputar esta fila
Rosalind Advisors, Inc. Common Shares9.910.987.104,0008/01/2025 Presentado el 11 ago 2025SCHEDULE 13G/AEnmienda 8Abrir presentación 0001579206-25-000008 Disputar esta fila
SALAMON STEVEN A J Common Shares9.910.987.104,0008/01/2025 Presentado el 11 ago 2025SCHEDULE 13G/AEnmienda 8Abrir presentación 0001579206-25-000008 Disputar esta fila
Aharon Gil Common Shares9.910.987.104,0008/01/2025 Presentado el 11 ago 2025SCHEDULE 13G/AEnmienda 8Abrir presentación 0001579206-25-000008 Disputar esta fila
Rosalind Master Fund L.P. Common Shares9.99.485.697,0008/01/2025 Presentado el 11 ago 2025SCHEDULE 13G/AEnmienda 8Abrir presentación 0001579206-25-000008 Disputar esta fila
Rosalind Opportunities Fund I L.P. Common Shares3.51.501.407,0008/01/2025 Presentado el 11 ago 2025SCHEDULE 13G/AEnmienda 8Abrir presentación 0001579206-25-000008 Disputar esta fila
Velan Capital Master Fund LP Common Stock, par value $0.0001 per share5.12.143.698,0007/30/2025 Presentado el 6 ago 2025SCHEDULE 13GAbrir presentación 0000921895-25-002116 Disputar esta fila
Velan Capital Holdings LLC Common Stock, par value $0.0001 per share5.12.143.698,0007/30/2025 Presentado el 6 ago 2025SCHEDULE 13GAbrir presentación 0000921895-25-002116 Disputar esta fila
Velan Capital Investment Management LP Common Stock, par value $0.0001 per share5.12.143.698,0007/30/2025 Presentado el 6 ago 2025SCHEDULE 13GAbrir presentación 0000921895-25-002116 Disputar esta fila
Velan Capital Management LLC Common Stock, par value $0.0001 per share5.12.143.698,0007/30/2025 Presentado el 6 ago 2025SCHEDULE 13GAbrir presentación 0000921895-25-002116 Disputar esta fila
Morgan Adam Common Stock, par value $0.0001 per share5.12.143.698,0007/30/2025 Presentado el 6 ago 2025SCHEDULE 13GAbrir presentación 0000921895-25-002116 Disputar esta fila
Venkataraman Balaji Common Stock, par value $0.0001 per share5.12.143.698,0007/30/2025 Presentado el 6 ago 2025SCHEDULE 13GAbrir presentación 0000921895-25-002116 Disputar esta fila
Craig Shore Common Stock, $0.0001 par value per share3.51.484.505,0006/26/2025 Presentado el 29 oct 2025SCHEDULE 13D/AEnmienda 1Abrir presentación 0001493152-25-020079 Disputar esta fila
Michael A. Lawless Common Stock, $0.0001 par value per share8.63.614.731,0006/26/2025 Presentado el 29 oct 2025SCHEDULE 13DAbrir presentación 0001493152-25-020078 Disputar esta fila
Rosalind Advisors, Inc. Common Shares9.410.987.104,0003/31/2025 Presentado el 11 ago 2025SCHEDULE 13G/AEnmienda 8Abrir presentación 0001579206-25-000005 Disputar esta fila

El porcentaje es de la clase que indica la presentación, según lo declaró el titular. Los miembros de un grupo informan cada uno las acciones del grupo, por lo que las filas no se suman.

Qué se leyó

2.092.408 presentaciones leídas, del 14 jun 2004 al 13 nov 2026: Formularios 3, 3/A, 4, 4/A, 5, 5/A.

Algunos años pueden estar incompletos mientras se sigue leyendo el archivo. Un año con pocas presentaciones aquí no afirma que se hicieran pocas.

Presentaciones leídas, por año de presentación
Año de presentaciónPresentaciones leídas
20151
2016204.322
2017202.494
2018202.048
2019193.638
2020144.184
2021224.474
202240.015
2023199.811
2024185.386
2025235.520
2026254.737

Las presentaciones anteriores a que la SEC exigiera XML se listan, pero no se extraen.

Volver a InspireMD, Inc.